Determinants of adherence in a cohort of Belgian HIV patients: a pilot study.

Abstract	Since the era of highly active antiretroviral therapy (HAART), HIV is considered a chronic disease. Adherence to HAART is crucial for effectiveness. Non-adherence negatively impacts patient outcome and the larger economy. However, data on adherence among the Belgian HIV cohort are scarce. Therefore, the purpose of this pilot study was to identify determinants of adherence among HIV patients treated in Belgium. The study was conducted at the Aids Reference Centre of Ghent University Hospital between 1 January and 31 December 2012. Sociodemographic data were collected, along with the Simplified Medication Adherence Questionnaire (SMAQ), the Center for Adherence Support Evaluation (CASE) Adherence Index, the EuroQol-6D, the Medical Outcomes Study-HIV (MOS-HIV), the Beck Depression Inventory-II, and three neurocognitive complaints screening questions. To date, 218 patients participated in the study, among whom 173 (79·4%) were male. Mean age was 46·0±10·6 years and 133 patients (63·9%) were homosexual. According to the SMAQ and the CASE, 78·5% and 93·5% of the patients were adherent to antiretroviral therapy. Logistic regression analysis revealed that smoking, neurocognitive complaints, and female sex were independent determinants of non-adherence. In conclusion, there is an elevated risk for non-adherence in smokers, people experiencing neurocognitive problems, and women in our sample. The latter could reflect differences between male and female HIV patients in Belgium. Adherence improving initiatives should be tailored to these three risk groups.
Authors	S Degroote, D Vogelaers, P Vermeir, A Mariman, A De Rick, B Van Der Gucht, J Pelgrom, F Van Wanzeele, C Verhofstede, J Vancauwenberghe, D Vandijck
Journal	Acta clinica Belgica (Acta Clin Belg) Vol. 69 Issue 2 Pg. 111-5 (Apr 2014) ISSN: 1784-3286 [Print] England
PMID	24724750 (Publication Type: Journal Article)
Chemical References	Anti-HIV Agents
Topics	Adult Anti-HIV Agents (therapeutic use) Antiretroviral Therapy, Highly Active (methods, standards) Belgium Female HIV Infections (drug therapy) Humans Logistic Models Male Medication Adherence Middle Aged Pilot Projects Surveys and Questionnaires

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!